Figure 2. Network pharmacological analysis of ICA targets. (A, B) PPI network construction and topological analysis revealed that MDM2 may be a common target of ICA in AD and ferroptosis. (C) Construction and visualization analysis of “medicinal material–component–target” network. (D, E) GO and KEGG enrichment analyses.